q2y≥6.5%diabetes65y.o.hypertensionTyrer-Cuzickmodel≥ 100mg/dL40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorPREVENTequationwomenage 55-64 y.o.cervicalcanceraspirin≥ 200mg/dLHIVovariancancer40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factordementiaq3yhormonetherapyq1yFractureRiskAssessmentToolcolorectalcancer75y.o.≥ 126mg/dLq1ymammogramHepatitisCq1-2ymammogrambased on lifeexpectancy /health status40-59 y.o.,ASCVD ≥10%, lowbleeding riskinsufficientevidenceforscreening52y.o.≥5.7%≤q2y40y.o.Timedup andgo test3%≥20%tamoxifentobaccouse60y.o.Gailmodel50y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorslungcancercardiovasculardiseasepneumococcalanxietycommunity-dwelling,postmenopausalwomen2 doses,2-6monthsapart40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsq15yherpeszostermultidoseinitial series,then 1 doseat 2-6monthsraloxifenearomataseinhibitorsstatin1 dose; 2doses (2-6monthsapart) ifimmunocompdyslipidemia≥ 140mg/dLHepatitisBq5yoverweight/ obesity< 60y.o.depressionbreastcancer40-70 y.o.,ASCVD ≥10%, lowbleeding riskq2y≥6.5%diabetes65y.o.hypertensionTyrer-Cuzickmodel≥ 100mg/dL40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorPREVENTequationwomenage 55-64 y.o.cervicalcanceraspirin≥ 200mg/dLHIVovariancancer40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factordementiaq3yhormonetherapyq1yFractureRiskAssessmentToolcolorectalcancer75y.o.≥ 126mg/dLq1ymammogramHepatitisCq1-2ymammogrambased on lifeexpectancy /health status40-59 y.o.,ASCVD ≥10%, lowbleeding riskinsufficientevidenceforscreening52y.o.≥5.7%≤q2y40y.o.Timedup andgo test3%≥20%tamoxifentobaccouse60y.o.Gailmodel50y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorslungcancercardiovasculardiseasepneumococcalanxietycommunity-dwelling,postmenopausalwomen2 doses,2-6monthsapart40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsq15yherpeszostermultidoseinitial series,then 1 doseat 2-6monthsraloxifenearomataseinhibitorsstatin1 dose; 2doses (2-6monthsapart) ifimmunocompdyslipidemia≥ 140mg/dLHepatitisBq5yoverweight/ obesity< 60y.o.depressionbreastcancer40-70 y.o.,ASCVD ≥10%, lowbleeding risk

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. q2y
  2. ≥ 6.5%
  3. diabetes
  4. 65 y.o.
  5. hypertension
  6. Tyrer-Cuzick model
  7. ≥ 100 mg/dL
  8. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  9. PREVENT equation
  10. women age 55-64 y.o.
  11. cervical cancer
  12. aspirin
  13. ≥ 200 mg/dL
  14. HIV
  15. ovarian cancer
  16. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  17. dementia
  18. q3y
  19. hormone therapy
  20. q1y
  21. Fracture Risk Assessment Tool
  22. colorectal cancer
  23. 75 y.o.
  24. ≥ 126 mg/dL
  25. q1y mammogram
  26. Hepatitis C
  27. q1-2y mammogram based on life expectancy / health status
  28. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  29. insufficient evidence for screening
  30. 52 y.o.
  31. ≥ 5.7%
  32. ≤ q2y
  33. 40 y.o.
  34. Timed up and go test
  35. 3%
  36. ≥ 20%
  37. tamoxifen
  38. tobacco use
  39. 60 y.o.
  40. Gail model
  41. 50 y.o.
  42. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  43. lung cancer
  44. cardiovascular disease
  45. pneumococcal
  46. anxiety
  47. community-dwelling, postmenopausal women
  48. 2 doses, 2-6 months apart
  49. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  50. q15y
  51. herpes zoster
  52. multidose initial series, then 1 dose at 2-6 months
  53. raloxifene
  54. aromatase inhibitors
  55. statin
  56. 1 dose; 2 doses (2-6 months apart) if immunocomp
  57. dyslipidemia
  58. ≥ 140 mg/dL
  59. Hepatitis B
  60. q5y
  61. overweight / obesity
  62. < 60 y.o.
  63. depression
  64. breast cancer
  65. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk